AAN 2022 and Aan 2022 View overview page

Subjective cognitive decline as a preclinical phase of Alzheimer’s disease

The importance of vascular disease in the management of dementia

Sufficient omega-3 consumption could help with the prevention of dementia in APOE4 carriers

Using imaging and blood biomarkers to assess the effect of nutrition on the development of dementia

Therapeutic potential of HDL and APOE in Alzheimer’s disease

Comparison of diagnostic criteria for dementia-related psychosis

Associations between neuropsychiatric symptoms and the progression of Alzheimer’s disease

Mechanisms behind development of neuropsychiatric symptoms in Alzheimer’s disease

Future research directions for neuropsychiatric symptoms in Alzheimer’s disease

How can we use telehealth to improve dementia care?

Importance of working with patients and families to improve quality of life for people with dementia

Biomarkers for frontotemporal dementia

A practical guide for diagnosing and treating memory loss

Resources to help patients and their families cope with dementia

Blood biomarkers for the diagnosis of Alzheimer’s disease

Diagnosing mild cognitive impairment